NDC 0093-3334

ALYQ

Tadalafil

ALYQ is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Tadalafil.

• Product ID: 0093-3334_122adfb3-69cb-4ec0-b620-a0d56ef0f1f4
• NDC: 0093-3334
• Product Type: Human Prescription Drug
• Proprietary Name: ALYQ
• Generic Name: Tadalafil
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2019-02-06
• Marketing Category: ANDA / ANDA
• Application Number: ANDA209942
• Labeler Name: Teva Pharmaceuticals USA, Inc.
• Substance Name: TADALAFIL
• Active Ingredient Strength: 20 mg/1
• Pharm Classes: Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 0093-3334-06

60 TABLET, FILM COATED in 1 BOTTLE (0093-3334-06)

• Marketing Start Date: 2019-02-06
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0093-3334-06 [00093333406]

ALYQ TABLET, FILM COATED

• Marketing Category: ANDA
• Application Number: ANDA209942
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-02-06

Drug Details

Active Ingredients

Ingredient	Strength
TADALAFIL	20 mg/1

OpenFDA Data

• SPL SET ID: 3a404db2-7a7d-476f-81cf-979a67d37f66
• Manufacturer:
  • Teva Pharmaceuticals USA, Inc.
• UNII:
  • 742SXX0ICT
• RxNorm Concept Unique ID - RxCUI:
  • 402019
  • 2110455
• UPC Code:
  • 0300933334068

Pharmacological Class

• Phosphodiesterase 5 Inhibitor [EPC]
• Phosphodiesterase 5 Inhibitors [MoA]

NDC Crossover Matching brand name "ALYQ" or generic name "Tadalafil"

NDC	Brand Name	Generic Name
0093-3334	ALYQ	Tadalafil
42291-804	ALYQ	ALYQ
0002-4462	Cialis	Tadalafil
0002-4463	Cialis	Tadalafil
0002-4464	Cialis	Tadalafil
0002-4465	Cialis	Tadalafil
0093-3016	Tadalafil	Tadalafil
0093-3017	Tadalafil	Tadalafil
0093-3018	Tadalafil	Tadalafil
0093-3019	Tadalafil	Tadalafil